TRENDING :  Market Movers  |  Top 50   FDX (-2.8%)    SPY (-1.93%)    AMZN (-3%)    VXXB (11.47%)    WYNN (-3.5%)    XLE (-2.71%)    XLF (-2.77%)    XLU (0.73%)    XRX (-5.6%)    ZUO (-14.06%)    BA (-2.83%)    BAC (-4.16%)    BIIB (-4.49%)    BPTH (18.94%)    CFMS (-1.65%)    CHKP (-0.58%)    CLRB (-6.1%)    CSIQ (-2.75%)    CVRS (2.72%)    CZZ (-7.45%)    DIS (-0.4%)    EVRI (-1.11%)    SQ (-4.39%)    TAC (-1.18%)    TARO (-0.12%)

 ILMN - Illumina

$308.79 [-10.42][-3.27%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $370.00
Low $288.00
Average $329.00
Current $308.79

CompanyAnalyst NamePT ActionActionRatingTargetDate
Morgan StanleySteve BeuchawLowersMaintainsHold$288.0001/07/19
*Last 90 days


Service NameTrader NamePosition TypeTarget %Target PriceTarget Date Issue Date
Seattle Stock Technical Breakout PlaysLesBuy Long28.24 %Subscribe08/28/1902/28/19View

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



SymbolService NamePosition TypeIssuePrice Target PriceClose Date% Return Comments
ILMNTopFlight Trades - Premium (Stocks)Buy Long$286.47$329.0007/20/188.63 %CommentsView
ILMNTopFlight Trades - Premium (Stocks)Buy Long$280.58$334.0007/20/1810.78 %CommentsView
ILMNAlpha Swing TradesBuy Long$227.87$245.0001/09/187.56 %CommentsView


Better Buy: Illumina vs. Guardant Health

Thanks to scientific breakthroughs we re living in an age of miracles according to David Gardner cofounder of The Motley Fool We ll examine two healthcare companies that are examples of modern day miracle makers to decide which stock is better positioned today Illumina

Has Illumina (ILMN) Outpaced Other Medical Stocks This Year?

Investors focused on the Medical space have likely heard of Illumina ILMN but is the stock performing well in comparison to the rest of its sector peers By taking a look at the stock s year to date performance in comparison to its Medical peers we might be able to answer that

What's Your DNA Worth? LunaDNA Will Help You Find Out

Genomics has very quickly grabbed the world s attention Businesses are developing new opportunities based directly on our DNA including wines meals and even artwork Direct to consumer DNA tests administered by 23andMe and Ancestry com are unlocking a new wave of

Better Buy: Exact Sciences vs. Illumina

Unleashing the power of DNA has been a ticket to success for Exact Sciences NASDAQ EXAS and Illumina NASDAQ ILMN Exact Sciences Cologuard DNA test for colorectal cancer is rapidly gaining momentum Meanwhile Illumina s gene sequencing systems have established the

Illumina (ILMN) Gains But Lags Market: What You Should Know

In the latest trading session Illumina ILMN closed at 309 84 marking a 0 21 move from the previous day This change lagged the S amp P 500 s 0 5 gain on the day Meanwhile the Dow gained 0 54 and the Nasdaq a tech heavy index added 0 76 Prior to today s trading shares of

LGND vs. ILMN: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals LGND or Illumina ILMN But which of these two stocks is more attractive to value investors We ll need to take a closer look to find out The best way to find

S&P 500 Analyst Moves: ILMN

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Illumina is now the 46 analyst pick moving up by 1 spot This rank is formed by averaging the analyst opinions for each component from each broker and then

Is Illumina a Buy?

No company has dominated gene sequencing like Illumina NASDAQ ILMN And the stock s performance has reflected that dominance Illumina s share price has skyrocketed more than 850 over the past 10 years Success isn t just a thing of the past for Illumina though The

Align Technology-Benco Dental Deal to Expand iTero Reach

In an attempt to widen iTero customer base Align Technology Inc ALGN recently announced a distribution agreement with Benco Dental Per the agreement starting Apr 1 Benco Dental will begin distributing iTero Element scanners in the United States Notably Benco Dental is a

Tandem's Global Growth a Boost, Operating Losses a Bane

On Mar 6 2019 we issued an updated research report on Tandem Diabetes Care Inc TNDM Tandem Diabetes expansion initiatives in the global market s are a major positive However the company s heavy dependence on the sales of insulin pumps and its recurring operating losses pose

GNC Holdings to Expand Portfolio With Alani Nutrition Deal

GNC Holdings Inc 160 GNC recently announced a retail and Amazon 160 partnership with Alani Nutrition Notably Alani Nutrition is a women s supplement brand offering a variety of health and sports nutrition products The company s product lines use filler free and simple ingredients and

GNC Forms Joint Venture With IVC to Improve Cost Efficiency

GNC Holdings Inc GNC recently announced forming a strategic joint venture with a vitamins and nutritional supplement manufacturer 160 International Vitamin Corporation IVC Through the joint venture GNC will integrate its manufacturing division with IVC Per management IVC

Why Illumina Stock Gained 12% in February

What happened Shares of biotech giant Illumina NASDAQ ILMN outpaced the market last month gaining 12 compared to a 3 increase in the S amp P 500 according to data provided by S amp P Global Market Intelligence The move added to solid returns for

Hologic (HOLX) Receives Global Nods for Omni Hysteroscope

In line with 160 Hologic Inc s HOLX focus to grow within the promising space of GYN Surgical the company recently announced encouraging global regulatory approvals for its Omni hysteroscope In this regard Health Canada issued a medical device license for Hologic s Omni hysteroscope

Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now

Hologic Inc 160 HOLX has been on a healthy growth trajectory of late The company s progress in the domestic and international markets a strong pipeline of products as well as huge prospects of the GYN Surgical and Molecular Diagnostics segments make it an attractive pick Thus this